Four biotechs doing their bit for the planet
27 Apr, 2026
How the biopharma operating model is shifting
27 Apr, 20262 minutes
At Mx Life Sciences, we track structural shifts shaping executive performance across biopharma leadership markets. Through board dialogue, search mandates, and leadership assessment work, one transformation has become increasingly clear:
The biopharma operating model is moving from vertically integrated global structures toward networked ecosystems of biotech innovators, CROs, CDMOs, academic institutions, and capital partners.
Research from PwC and EY highlights a decisive trend: a growing majority of late-stage pipeline value now originates externally rather than from internal R&D engines.
This shift is not cyclical. It reflects a structural redesign of how value is created, accessed, and scaled.
What’s Changed?
Traditional Model → Networked Model
Centralized authority → Distributed governance
Internal R&D ownership → External innovation sourcing
Control of resources → Shared/contracted capability
Hierarchical execution → Cross-entity orchestration
In the traditional model, performance was driven by scale, depth of internal capabilities, and vertical control.
In the networked model, performance depends on:
- Partner selection and portfolio construction
- Alliance governance quality
- Milestone synchronization across independent entities
- Capital-efficient integration of external assets
Value creation increasingly happens at the interface between organisations, not within a single enterprise boundary.
Structural Drivers Behind the Shift:
- R&D productivity pressures and rising development costs
- Scientific specialisation within biotech innovation clusters
- Capital discipline in large pharma
- Speed-to-market competition
- Regulatory and data complexity
- Growth of specialist CRO and CDMO capabilities
Reports from Deloitte have consistently shown declining internal R&D returns across large pharmaceutical organisations, further accelerating external sourcing strategies.
What This Means for Executive Hiring
As operating models become ecosystem-driven, executive success profiles are being repriced.
Leadership effectiveness is shifting from authority-based execution to influence-based orchestration.
Transition Risk Is Rising For:
- Leaders built exclusively in centralised, hierarchical environments
- Executives reliant on formal authority and direct control
- Profiles with limited exposure to external partnership governance
- Leaders whose track records depend primarily on scale rather than complexity
These executives may struggle in distributed environments where outcomes depend on alignment, negotiation, and cross-boundary influence.
Capabilities Increasing in Value:
- Alliance and partnership leadership
- Ecosystem orchestration across multiple stakeholders
- Cross-organisation governance design
- Incentive alignment across conflicting timelines and capital priorities
- Delivery of outcomes without direct P&L or resource ownership
- Ability to manage scientific, commercial, and investor expectations simultaneously
In a networked model, influence capital increasingly determines performance outcomes.
Executives who can align stakeholders without formal control create disproportionate enterprise value.
Executive Assessment Lens
Boards and CEOs should stress-test leadership against ecosystem complexity.
Key Diagnostic Questions:
- Where has this leader delivered measurable results without direct authority?
- Can they cite a partnership where they owned outcomes but not resources?
- How did they align incentives across organisations with conflicting priorities or timelines?
- What governance structures did they design to manage risk across entities?
- What is the most complex external ecosystem they have orchestrated (biotech, CROs, CDMOs, academia)?
- What failed before it ultimately worked — and what structural changes were implemented?
Leadership assessment frameworks designed for hierarchical models may no longer be sufficient.
Strategic Implications for Boards:
- Re-evaluate succession pipelines for ecosystem readiness
- Recalibrate executive evaluation criteria
- Stress-test internal high performers against distributed governance complexity
- Consider external hires with proven cross-entity orchestration track records
The competitive advantage increasingly lies not in asset ownership — but in ecosystem leadership.
Conclusion
The operating model has permanently shifted.
In a networked ecosystem, value is created at the intersection of independent organisations, not within controlled hierarchies.
Leadership teams built for authority-based execution will increasingly struggle in influence-based environments.
Those built for ecosystem orchestration will:
- Accelerate innovation integration
- Reduce alliance friction
- Improve milestone reliability
- Protect enterprise value
The critical question is no longer strategy. It is whether leadership capability is aligned with the operating model that strategy now depends upon.
Related Posts
